header
Local cover image
Local cover image
Image from OpenLibrary

A pharmaceutical study on certain modified release etodolac dosage forms / Ahmed Adel Mohamed Alaa Eldin ; Supervised Ahmed Abdelbary Abdelrahman , Mina Ibrahim Tadros

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Ahmed Adel Mohamed Alaa Eldin , 2010Description: 200 P. : charts ; 25cmOther title:
  • دراسة صيدلية على بعض الأشكال الصيدلية محورة الأنطلاق لعقار الإيتودولاك [Added title page title]
Subject(s): Online resources: Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics Summary: Etodolac is non - steroidal anti - inflammatory drug acting by a preferential inhibition of cyclo - oxygenase - 2 ( COX - 2 ) enzyme . It is used for rheumatoid arthritis , including juvenile idiopathic arthritis , osteoathritis and for the treatment of acute pain . It has an elimination half - life of 7 hour and the recommended oral dose , 200 to 400 mg, is given every 6 to 8 hours to a maximum of 1.2 g daily , therefore it is a potential cadidate for controlled release formulations
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.08.M.Sc.2010.Ah.P (Browse shelf(Opens below)) Not for loan 01010110054638000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.08.M.Sc.2010.Ah.P (Browse shelf(Opens below)) 54638.CD Not for loan 01020110054638000

Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics

Etodolac is non - steroidal anti - inflammatory drug acting by a preferential inhibition of cyclo - oxygenase - 2 ( COX - 2 ) enzyme . It is used for rheumatoid arthritis , including juvenile idiopathic arthritis , osteoathritis and for the treatment of acute pain . It has an elimination half - life of 7 hour and the recommended oral dose , 200 to 400 mg, is given every 6 to 8 hours to a maximum of 1.2 g daily , therefore it is a potential cadidate for controlled release formulations

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer

Local cover image